Beta 3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation

Journal of the American College of Cardiology

Volumn 58, Issue 25, 2011, Pages 2683-2691

  Aragón, Juan P ^a   Condit, Marah E ^a   Bhushan, Shashi ^a   Predmore, Benjamin L ^a   Patel, Sandeep S ^b   Grinsfelder, D Bennett ^a   Gundewar, Susheel ^b   Jha, Saurabh ^b   Calvert, John W ^a   Barouch, Lili A ^c   Lavu, Madhav ^a   Wright, Harold M ^d   Lefer, David J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FOREST RESEARCH INSTITUTE   (United States)

Author keywords

beta 3 adrenergic receptor; cardiac ischemia; endothelial nitric oxide synthase; neuronal nitric oxide synthase; nitric oxide

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEBIVOLOL; NEURONAL NITRIC OXIDE SYNTHASE; NITRITE; SERINE; TROPONIN I; BENZOPYRAN DERIVATIVE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ETHANOLAMINE DERIVATIVE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; TROPONIN I BLOOD LEVEL; ANIMAL; BIOAVAILABILITY; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BENZOPYRANS; BIOLOGICAL AVAILABILITY; DISEASE MODELS, ANIMAL; ETHANOLAMINES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ADRENERGIC, BETA-3;

EID: 82955217769     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.09.033     Document Type: Article

References (51)

1. R. Bolli Mechanism of myocardial "stunning." Circulation 82 1990 723 738
2. M. Ovize, G.F. Baxter, and F. Di Lisa Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc Res 87 2010 406 423
3. G. Heusch Postconditioning: old wine in a new bottle? J Am Coll Cardiol 44 2004 1111 1112 (Pubitemid 39165148)
4. A. Hjalmarson, J. Herlitz, and S. Holmberg The Goteborg Metoprolol Trial Effects on mortality and morbidity in acute myocardial infarction Circulation 67 1983 I26 I32
5. M.J. Lohse, S. Engelhardt, and T. Eschenhagen What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 2003 896 906 (Pubitemid 37433227)
6. S. Reiken, X.H. Wehrens, and J.A. Vest Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure Circulation 107 2003 2459 2466 (Pubitemid 36605229)
7. C. Communal, K. Singh, D.B. Sawyer, and W.S. Colucci Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein Circulation 100 1999 2210 2212
8. C. Morisco, D.C. Zebrowski, D.E. Vatner, S.F. Vatner, and J. Sadoshima Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart J Mol Cell Cardiol 33 2001 561 573 (Pubitemid 32539011)
9. C. Gauthier, G. Tavernier, F. Charpentier, D. Langin, and H. Le Marec Functional beta3-adrenoceptor in the human heart J Clin Invest 98 1996 556 562
10. B. Rozec, and C. Gauthier beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies Pharmacol Ther 111 2006 652 673 (Pubitemid 44137382)
11. M.R. Bristow, P. Nelson, W. Minobe, and C. Johnson Characterization of β1-adrenergic receptor selectivity of nebivolol and various other beta-blockers in human myocardium (abstr) Am J Hypertens 18 2005 51A 52A
12. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225 (Pubitemid 40222359)
13. L.J. Ignarro Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol Cardiovasc Ther 26 2008 115 134 (Pubitemid 351952828)
14. A. Kuroedov, F. Cosentino, and T.F. Luscher Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol Cardiovasc Drug Rev 22 2004 155 168 (Pubitemid 39391186)
15. A. Maffei, and G. Lembo Nitric oxide mechanisms of nebivolol Ther Adv Cardiovasc Dis 3 2009 317 327
16. J.L. Balligand beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?" J Am Coll Cardiol 53 2009 1539 1542
17. C. Dessy, J. Saliez, and P. Ghisdal Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol Circulation 112 2005 1198 1205 (Pubitemid 41216127)
18. M.A. Broeders, P.A. Doevendans, and B.C. Bekkers Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production Circulation 102 2000 677 684 (Pubitemid 30640669)
19. A. Georgescu, F. Pluteanu, M.L. Flonta, E. Badila, M. Dorobantu, and D. Popov The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery Eur J Pharmacol 508 2005 159 166 (Pubitemid 40169915)
20. T.T. Quang, B. Rozec, L. Audigane, and C. Gauthier Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta Br J Pharmacol 156 2009 601 608
21. M.R. Duranski, J.J. Greer, and A. Dejam Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver J Clin Invest 115 2005 1232 1240 (Pubitemid 40629041)
22. R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res 61 2004 402 413 (Pubitemid 38210147)
23. G. Heusch, K. Boengler, and R. Schulz Cardioprotection: nitric oxide, protein kinases, and mitochondria Circulation 118 2008 1915 1919
24. N.S. Bryan, J.W. Calvert, S. Gundewar, and D.J. Lefer Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice Free Radic Biol Med 45 2008 468 474
25. S.P. Jones, W.G. Girod, and A.J. Palazzo Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am J Physiol 276 1999 H1567 H1573
26. B.R. Sharp, S.P. Jones, D.M. Rimmer, and D.J. Lefer Differential response to myocardial reperfusion injury in eNOS-deficient mice Am J Physiol Heart Circ Physiol 282 2002 H2422 H2426
27. K.E. Loke, S.K. Laycock, and S. Mital Nitric oxide modulates mitochondrial respiration in failing human heart Circulation 100 1999 1291 1297 (Pubitemid 29440121)
28. U. Walter, and S. Gambaryan Roles of cGMP/cGMP-dependent protein kinase in platelet activation Blood 104 2004 2609 (Pubitemid 39331870)
29. A.L. Moens, J.S. Leyton-Mange, and X. Niu Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor J Mol Cell Cardiol 47 2009 576 585
30. V.S. Susulic, R.C. Frederich, and J. Lawitts Targeted disruption of the beta 3-adrenergic receptor gene J Biol Chem 270 1995 29483 29492
31. S.P. Jones, J.J. Greer, and A.K. Kakkar Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol 286 2004 H276 H282
32. G.M. McKnight, L.M. Smith, R.S. Drummond, C.W. Duncan, M. Golden, and N. Benjamin Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans Gut 40 1997 211 214 (Pubitemid 27093095)
33. B. Rozec, M. Erfanian, K. Laurent, J.N. Trochu, and C. Gauthier Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart J Am Coll Cardiol 53 2009 1532 1538
34. J.A. Dolan, H.A. Muenkel, and M.G. Burns Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines J Pharmacol Exp Ther 269 1994 1000 1006 (Pubitemid 24204180)
35. P. Muzzin, J. Seydoux, J.P. Giacobino, J.C. Venter, and C. Fraser Discrepancies between the affinities of binding and action of the novel beta-adrenergic agonist BRL 37344 in rat brown adipose tissue Biochem Biophys Res Commun 156 1988 375 382
36. O.E. Brodde Cardiac beta-adrenergic receptors ISI Atlas of Science 1987 107 112
37. L.J. Emorine, S. Marullo, and M.M. Briend-Sutren Molecular characterization of the human beta 3-adrenergic receptor Science 245 1989 1118 1121 (Pubitemid 19231821)
38. C. Nahmias, N. Blin, J.M. Elalouf, M.G. Mattei, A.D. Strosberg, and L.J. Emorine Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes EMBO J 10 1991 3721 3727 (Pubitemid 21905399)
39. F. Nantel, H. Bonin, and L.J. Emorine The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization Mol Pharmacol 43 1993 548 555 (Pubitemid 23112732)
40. K. Brixius, W. Bloch, and C. Pott Mechanisms of beta 3-adrenoceptor- induced eNOS activation in right atrial and left ventricular human myocardium Br J Pharmacol 143 2004 1014 1022 (Pubitemid 40065502)
41. J.R. Arch beta(3)-adrenoceptor agonists: potential, pitfalls and progress Eur J Pharmacol 440 2002 99 107 (Pubitemid 34458017)
42. J. Loscalzo, and G. Welch Nitric oxide and its role in the cardiovascular system Prog Cardiovasc Dis 38 1995 87 104
43. M.R. Candelore, L. Deng, and L. Tota Potent and selective human beta(3)-adrenergic receptor antagonists J Pharmacol Exp Ther 290 1999 649 655 (Pubitemid 29344558)
44. C. Hoffmann, M.R. Leitz, S. Oberdorf-Maass, M.J. Lohse, and K.N. Klotz Comparative pharmacology of human beta-adrenergic receptor subtypescharacterization of stably transfected receptors in CHO cells Naunyn Schmiedebergs Arch Pharmacol 369 2004 151 159 (Pubitemid 38270770)
45. N. Niclauss, M.B. Michel-Reher, A.E. Alewijnse, and M.C. Michel Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes Naunyn Schmiedebergs Arch Pharmacol 374 2006 99 105 (Pubitemid 44657616)
46. J. Amour, X. Loyer, and M. Le Guen Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide Anesthesiology 107 2007 452 460 (Pubitemid 47329544)
47. A. Maffei, A. Di Pardo, and R. Carangi Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation Hypertension 50 2007 652 656 (Pubitemid 47442727)
48. C. Gauthier, V. Leblais, and L. Kobzik The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle J Clin Invest 102 1998 1377 1384 (Pubitemid 28467566)
49. S.A. Sorrentino, C. Doerries, and C. Manes Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade J Am Coll Cardiol 57 2011 601 611
50. K. Matsumura, I. Abe, T. Tsuchihashi, and M. Fujishima Central nitric oxide attenuates the baroreceptor reflex in conscious rabbits Am J Physiol 274 1998 R1142 R1149
51. J.F. Paton, J. Deuchars, Z. Ahmad, L.F. Wong, D. Murphy, and S. Kasparov Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat J Physiol 531 2001 445 458 (Pubitemid 32232943)